Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
HAO 
Haoxi Health Technology Limited Class A Ordinary Shares (HAO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: HAO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit 0% | Avg. Invested days 0 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 3.77M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 1.28 | 52 Weeks Range 1.02 - 173.25 | Updated Date 06/29/2025 |
52 Weeks Range 1.02 - 173.25 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.85 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.61% | Operating Margin (TTM) -0.53% |
Management Effectiveness
Return on Assets (TTM) 3.42% | Return on Equity (TTM) 2.92% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -4130603 | Price to Sales(TTM) 0.08 |
Enterprise Value -4130603 | Price to Sales(TTM) 0.08 | ||
Enterprise Value to Revenue 0.63 | Enterprise Value to EBITDA 17.37 | Shares Outstanding 2205800 | Shares Floating 1686284 |
Shares Outstanding 2205800 | Shares Floating 1686284 | ||
Percent Insiders 21.79 | Percent Institutions 5.78 |
Upturn AI SWOT
Haoxi Health Technology Limited Class A Ordinary Shares
Company Overview
History and Background
Haoxi Health Technology Limited is a company in the health technology sector. Information on its founding year, milestones, and specific evolution are not publicly available without access to proprietary databases.
Core Business Areas
- E-commerce platform: The company operates an e-commerce platform focusing on health and wellness products, including over-the-counter medications, nutritional supplements, and medical devices.
- Online healthcare services: Offers services such as online consultations with doctors, prescription refills, and health information resources.
Leadership and Structure
Due to limited public information, specifics on the leadership team and organizational structure of Haoxi Health Technology Limited are unavailable.
Top Products and Market Share
Key Offerings
- Over-the-counter (OTC) medications: A wide range of non-prescription medications catering to common health needs. Market share data is not publicly available, but major competitors in the OTC medication market include Johnson & Johnson, Bayer, and GlaxoSmithKline.
- Nutritional supplements: Various vitamins, minerals, and other supplements to promote health and wellness. Market share data is not publicly available. Competitors include Herbalife Nutrition, Amway, and Nature's Bounty.
- Medical Devices: Basic consumer medical devices like blood pressure monitors, thermometers. Market share data not publicly available. Competitors include Omron Healthcare, and Philips Healthcare (for the consumer products line).
Market Dynamics
Industry Overview
The health technology industry is experiencing significant growth due to increasing demand for convenient healthcare solutions, rising healthcare costs, and technological advancements. The market is becoming more competitive with many players.
Positioning
Haoxi Health Technology Limited aims to capture a portion of the growing online healthcare market. Specific competitive advantages are unclear without further information.
Total Addressable Market (TAM)
The global digital health market is estimated to reach hundreds of billions of dollars. Haoxi Health Technology Limited's positioning depends on its ability to scale its operations and attract a significant user base. Without specifics, it is hard to identify their market positioning to the TAM.
Upturn SWOT Analysis
Strengths
- E-commerce platform for healthcare products
- Potential for online healthcare service integration
- Access to a growing market
- Established Distribution Channels
Weaknesses
- Lack of public information makes detailed assessment difficult
- Limited brand recognition compared to established players
- Dependence on regulatory approvals for certain products and services
Opportunities
- Expanding product offerings to include specialized healthcare products
- Forming partnerships with healthcare providers
- Leveraging technology to improve customer experience
- Geographic expansion
Threats
- Intense competition from established e-commerce and healthcare companies
- Changing regulatory landscape
- Data security and privacy concerns
- Economic downturn
Competitors and Market Share
Key Competitors
- JD.com (JD)
- Alibaba Health (Not US traded)
- Ping An Healthcare and Technology Company Limited (Not US traded)
Competitive Landscape
The competitive landscape is characterized by intense rivalry among e-commerce platforms and established healthcare providers. Advantages and disadvantages depend on factors such as product offerings, pricing strategies, and customer service.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends cannot be determined without access to financial records.
Future Projections: Future growth projections depend on factors such as market conditions, competitive landscape, and company-specific strategies. Analyst estimates are unavailable.
Recent Initiatives: Information on recent strategic initiatives is not publicly accessible.
Summary
Haoxi Health Technology Limited operates in the promising health technology sector, offering e-commerce and potentially online healthcare services. Limited publicly available data makes it challenging to assess its financial health and competitive positioning definitively. The company faces competition from established players and needs to navigate a complex regulatory environment. Securing strategic partnerships and expanding its service offerings could be beneficial. Future growth hinges on its ability to differentiate itself and address key market challenges.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Publicly available information, industry reports, competitor analysis
Disclaimers:
This analysis is based on limited publicly available information and may not reflect the complete financial picture of Haoxi Health Technology Limited. Market share data is estimated.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Haoxi Health Technology Limited Class A Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2008-01-30 | Chairman & CEO Mr. Zhen Fan | ||
Sector Communication Services | Industry Advertising Agencies | Full time employees 30 | Website https://www.haoximedia.com |
Full time employees 30 | Website https://www.haoximedia.com | ||
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. The company offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. It places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. The company serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.